131 related articles for article (PubMed ID: 4971964)
1. [The significance of connective tissue stimulation in antitumor chemotherapy].
Diadosha GF; Bulkina ZP; Kononenko LI
Vopr Onkol; 1968; 14(9):70-3. PubMed ID: 4971964
[No Abstract] [Full Text] [Related]
2. [The mechanism of tumor drug resistance].
Kulik GI
Vopr Onkol; 1969; 15(11):60-4. PubMed ID: 5368841
[No Abstract] [Full Text] [Related]
3. Comparative antitumor effects of peptichemio and other alkylating agents.
Schmid FA; Banks SE; Stock CC
Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145
[No Abstract] [Full Text] [Related]
4. The need for additional alkylating agents.
Connors TA
Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691
[No Abstract] [Full Text] [Related]
5. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].
Kulik GI
Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230
[No Abstract] [Full Text] [Related]
6. [Quantitative evaluation of the efficacy of antineoplastic agents].
Karavainova MKh
Farmakol Toksikol; 1971; 34(5):618-21. PubMed ID: 5004886
[No Abstract] [Full Text] [Related]
7. 3-N,N-bis(2-chloroethylamino)p-toluic acid, a new cytostatic drug active in cancer.
Dobre V; Maltezeanu G
Cancer Chemother Rep; 1970 Oct; 54(5):319-23. PubMed ID: 5514620
[No Abstract] [Full Text] [Related]
8. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
Sugiura K; Merker PC
Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
[No Abstract] [Full Text] [Related]
9. Chemotherapy of breast cancer.
Hall TC
Clin Obstet Gynecol; 1968 Jun; 11(2):401-15. PubMed ID: 4972174
[No Abstract] [Full Text] [Related]
10. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
Ujházy V
Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
[No Abstract] [Full Text] [Related]
11. Attempt to increase the effect of regional chemotherapy in experimental tumours by procaine.
Godál A; Medzihradský J; Knotek J; Ujházy V
Neoplasma; 1969; 16(4):389-92. PubMed ID: 5344224
[No Abstract] [Full Text] [Related]
12. [The effect of zymosan on the toxicity and activity of various antitumor preparations].
Veksler IG
Vopr Onkol; 1966; 12(8):80-6. PubMed ID: 4972211
[No Abstract] [Full Text] [Related]
13. [Selectivity of the antitumor action of 2 alkylating compounds with different carrier structures].
Astardzhieva Z; Stoichkov I
Eksp Med Morfol; 1988; 27(2):14-7. PubMed ID: 3168903
[No Abstract] [Full Text] [Related]
14. [Therapy of lymphogranulomatosis].
Hennemann HH
Dtsch Med Wochenschr; 1969 Mar; 94(13):664-6. PubMed ID: 4180636
[No Abstract] [Full Text] [Related]
15. Experimental study on the antitumoral activity of some N-mustards derivatives of the L-asparagic acid.
Năstasă V; Sunel V; Dăneţ D; Dăneţ R
Rev Med Chir Soc Med Nat Iasi; 1983; 87(4):619-22. PubMed ID: 6676886
[No Abstract] [Full Text] [Related]
16. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
Mayo JG
Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy in isolation perfusion: use of mitotic inhibitors in pretreatment of V x 2 carcinoma undergoing isolation perfusion with alkylating agents.
Mashima Y; Nagatsu M; Lambert A
Cancer Chemother Rep; 1972 Apr; 56(2):175-81. PubMed ID: 5043225
[No Abstract] [Full Text] [Related]
18. [Role of immunity in the action of sarcolysine and other preparations].
Syrkin AB; Solenov VN; Bodiagin DA; Zaĭtseva LA
Vestn Akad Med Nauk SSSR; 1971; 26(3):55-9. PubMed ID: 5581445
[No Abstract] [Full Text] [Related]
19. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs.
Geran RI; Congleton GF; Dudeck LE; Abbott BJ; Gargus JL
Cancer Chemother Rep 2; 1974 Dec; 4(4):53-87. PubMed ID: 4447935
[No Abstract] [Full Text] [Related]
20. [Vitamin B-12 in the chemotherapy of experimental tumors].
Bulkina ZP; Poliak NR
Vopr Onkol; 1968; 14(4):70-5. PubMed ID: 4969819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
